Document is current
Any future updates will be listed below
-
Authors
Ooi, Soo Liang https://orcid.org/0000-0002-0534-3673
Micalos, Peter S. https://orcid.org/0000-0002-7238-3878
Zielinski, Robert https://orcid.org/0000-0002-4807-8523
Lacey, Judith https://orcid.org/0000-0002-3751-406X
Grant, Suzanne https://orcid.org/0000-0002-9491-203X
Kao, Steven https://orcid.org/0000-0003-4531-7397
Golombick, Terry https://orcid.org/0009-0009-5369-1013
Pak, Sok Cheon https://orcid.org/0000-0001-8510-5781
-
Funding
Funding for this research was provided by:
Daiwa Pharmaceutical Co., Ltd. (Private Treaty)
BioMedica Nutraceuticals Pty Ltd. (Private Treaty)
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 20 February 2026
First Online: 2 March 2026
Declarations
:
: This study was approved by the Human Research Ethics Committee (HREC) of Concord Repatriation General Hospital, Sydney Local Health District (Application No. 2019/ ETH00489) and Charles Sturt University HREC (Protocol No. H19244). All participants in the study provided written informed consent before starting the trial.
: The manuscript has been read and approved by all named authors, and there are no other persons who satisfied the criteria for authorship but are not listed. All authors had agreed to the publication. The manuscript contains no participant’s personal data in any form.
: The authors declare no competing interests.
